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A B S T R A C T
Background
Surgical site infections (SSIs) are wound infections that occur after invasive (surgical) procedures. Preoperative bathing or showering
with an antiseptic skin wash product is a well-accepted procedure for reducing skin bacteria (microflora). It is less clear whether reducing
skin microflora leads to a lower incidence of surgical site infection.
Objectives
To review the evidence for preoperative bathing or showering with antiseptics for preventing hospital-acquired (nosocomial) surgical
site infections.
Search methods
For this third update we searched the Cochrane Wounds Group Specialised Register (searched 5 November 2010), the Cochrane
Central Register of Controlled Trials (The Cochrane Library Issue 4, 2010), Ovid MEDLINE (January 2008 to November Week 2
2010), Ovid EMBASE (2008 to 2010 Week 42), EBSCO CINAHL (2008 to 5 October 2010) and reference lists of articles.
Selection criteria
Randomised controlled trials comparing any antiseptic preparation used for preoperative full-body bathing or showering with non-
antiseptic preparations in people undergoing surgery.
Data collection and analysis
Two review authors independently assessed studies for selection, quality and extracted data. Study authors were contacted for additional
information.
Main results
No new trials were included in this third update. Seven trials involving a total of 10,157 participants were included. Four of the included
trials had three comparison groups. The antiseptic used in all trials was 4% chlorhexidine gluconate (Hibiscrub/Riohex). Three trials
involving 7791 participants compared chlorhexidine with a placebo. Bathing with chlorhexidine compared with placebo did not result
in a statistically significant reduction in SSIs; the relative risk of SSI (RR) was 0.91 (95% confidence interval (CI) 0.80 to 1.04). When
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only trials of high quality were included in this comparison, the RR of SSI was 0.95 (95%CI 0.82 to 1.10). Three trials of 1443
participants compared bar soap with chlorhexidine; when combined there was no difference in the risk of SSIs (RR 1.02, 95% CI 0.57
to 1.84). Three trials of 1192 patients compared bathing with chlorhexidine with no washing, one large study found a statistically
significant difference in favour of bathing with chlorhexidine (RR 0.36, 95%CI 0.17 to 0.79). The smaller studies found no difference
between patients who washed with chlorhexidine and those who did not wash preoperatively.
Authors’ conclusions
This review provides no clear evidence of benefit for preoperative showering or bathing with chlorhexidine over other wash products, to
reduce surgical site infection. Efforts to reduce the incidence of nosocomial surgical site infection should focus on interventions where
effect has been demonstrated.
P L A I N L A N G U A G E S U M M A R Y
Preoperative bathing or showering with skin antiseptics to prevent surgical site infection
Surgical site infection is a serious complication of surgery and is usually associated with increased length of hospital stay for the patient,
and also higher hospital costs. The use of an antiseptic solution for preoperative bathing or showering is widely practiced in the belief
that it will help to prevent surgical site infections from developing. This review identified seven trials, with over 10,000 patients, that
tested skin antiseptics (chlorhexidine solution) against normal soap or no presurgical washing. The review of these trials did not show
clear evidence that the use of chlorhexidine solution before surgery was better than other wash products at preventing surgical site
infections from developing after surgery.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
pre-operative showering with Chlorhexidine 4% compared with placebo for surgical patients
Patient or population: surgical patients
Settings: hospitals
Intervention: pre-operative showering with Chlorhexidine 4%
Comparison: placebo
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
placebo pre-operative showering
with Chlorhexidine 4%
Surgical site infection
Follow-up: 1 - 6 weeks1
Low risk population RR 0.91
(0.8 to 1.04)
7791
(4 studies)
⊕⊕⊕⊕
high2
30 per 1000 27 per 1000
(24 to 31)
High risk population
100 per 1000 91 per 1000
(80 to 104)
Allergic reaction
Follow-up: 1 - 6 weeks1
Study population RR 0.89
(0.36 to 2.19)
3589
(2 studies)
⊕⊕⊕©
moderate3
6 per 1000 5 per 1000
(2 to 13)
Medium risk population
3 per 1000 3 per 1000
(1 to 7)
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*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Some studies followed patients only until hospital discharge; however, as these studies are over 20 years old, we have assumed 7
days.
2 In one trial, five months into the study, the placebo solution was found to contain a microbiological agent. The solution was changed
for the remaining 17 months of the trial. There was a total of over 7,000 participants included in this outcome, so we do not believe that
the overall effect estimate would have been substantially altered.
3 Only 19 events were reported. All of these were from one trial.
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B A C K G R O U N D
Surgical site infections (SSIs) are wound infections that occur after
invasive (surgical) procedures. SSI is the thirdmost frequently hos-
pital-acquired (nosocomial) infection amongst hospital patients
(Smyth 2000). The Centers for Disease Control and Prevention
(CDC) have used the National Nosocomial Infections Surveil-
lance system (NNIS) to monitor nosocomial infections in acute
care hospitals in the United States since 1970. Between 1986 and
1996 the CDC studied approximately 600,000 operations. Surgi-
cal site infections developed after three per cent (15,523) of these
operations.During the period of data collection, 551 of the 15,523
patients who developed an SSI died, and 77% of deaths were at-
tributed to the infection (Mangram 1999). Apart from the mor-
bidity and mortality associated with surgical site infections, there
are significant cost implications. A study, using the NNIS system
found that it cost over USD 3000 more to treat a patient with an
SSI than a non-infected patient. These costs were attributable to a
greater likelihood of admission to an intensive care unit, a longer
than usual post-operative stay (five days), and an increased rate of
hospital re-admission (Kirkland 1999). Potential litigation is also a
concern (Rubinstein 1999). Consequently, prevention of surgical
site infection has become a priority for health care facilities.
An SSI is defined as an infection occurring within 30 days af-
ter an operation, and involves either a discharge of pus (purulent
discharge), with or without laboratory confirmation; an organism
isolated from an aseptically obtained culture; or signs and symp-
toms of infection, such as localised swelling, redness, or tenderness
(Mangram 1999). The CDC have developed a set of standard-
ised criteria for defining SSI in an attempt to make surveillance
and rate calculation more accurate and amenable to comparison
(Mangram 1999). SSIs are classified as being: superficial incisional
(involving only skin or subcutaneous tissues); deep incisional (in-
volving deeper soft tissue and fascia); or organ/space (involving
any other part of the anatomy that was opened or manipulated).
To help predict the likelihood, or SSI risk, surgical sites can be as-
sessed preoperatively and classified into one of four categories with
clear definitions: Class 1 (clean), Class II (clean-contaminated),
Class III (contaminated) and Class IV (dirty/infected) (Mangram
1999). Clean wounds are defined as uninfected surgical wounds
in which the respiratory, alimentary, genital or uninfected urinary
tract are not present and in which no inflammation is encoun-
tered. Non-clean wounds are defined according to the anatomical
area of operation, cause (aetiology) of wound, presence of existing
clinical infection, and intra-operative contamination. Since clean
wounds are less likely to become infected, SSIs following clean
surgery are usually associated with either: (1) patient risk factors,
such as age, nutritional status, diabetes and obesity; (2) risk fac-
tors related to the procedure: including incomplete preoperative
hand and forearm antisepsis by one of the surgical team, length of
surgical procedure and surgical technique; or (3) risk factors asso-
ciated with preoperative preparation of the patient: for example,
antimicrobial prophylaxis, preoperative hair removal and preop-
erative antiseptic showering (Mangram 1999).
Skin is not sterile. Indeed, thousands of bacteria live permanently
on skin and contribute to health by maintaining a steady colony
that inhibits establishment of harmful yeast and fungal infections.
These bacterial populations are referred to as the ’resident flora’. A
number of bacteria are present on the skin for a short period due to
transfer from other people or the environment, and these consti-
tute the ’transient flora’. At present, whole body bathing or show-
ering with skin antiseptic to prevent SSIs is a widespread practice
before surgery. The aim of washing is to make the skin as clean
as possible by removing transient flora and some resident flora.
Chlorhexidine 4% in detergent (’Hibiscrub’ or ’Hibiclens’) or a
triclosan preparation is usually used for this purpose, and there
is evidence that the numbers of bacteria on the skin are reduced
when it is applied (Byrne 1991; Kaiser 1988). Moreover, use of
a skin antiseptic on consecutive days not only reduces microbial
counts from baseline measurements, but also reduces the counts
progressively over time (Paulson 1993). Although this body of ev-
idence demonstrates the effectiveness of antiseptics as skin cleans-
ing agents, the more important question is whether preoperative
bathing or showering with an antiseptic reduces the incidence of
SSI. In a 10-year prospective surveillance study, the SSI rate was
lower amongst patients showering with hexachlorophene before
surgery than in those who either did not shower or showered us-
ing a non-medicated soap (Cruse 1980). In addition, at least two
studies have used a before-and-after design to test the effect of in-
troducing preoperative showering with triclosan to control methi-
cillin-resistant Staphylococcus aureus (MRSA) SSIs. In the first of
these, showering before and after surgery was introduced to reduce
the MRSA SSI rate. This intervention, however, was only one of
a battery of measures introduced, so it was not possible to de-
termine the independent effect of preoperative showering (Brady
1990). In the second, the incidence of MRSA SSI was reduced
amongst orthopaedic patients after presurgical showering with tri-
closan was introduced, however, the patients were also treated with
nasal mupirocin for five days before surgery (Wilcox 2003).While
these observational studies provide some support for the practice
of preoperative showering with an antiseptic, the evidence is not
definitive.
Patterns of resistance have developed with some antiseptics
(Thomas 2000), leading to calls to restrict their use to situations
where effectiveness can be demonstrated. In addition, hypersensi-
tivity to chlorhexidine on the part of the patient is not uncommon.
Consequently, the potential benefit of bathing or showering with
antiseptics needs to be assessed alongside their potential for harm
(Beaudounin 2004; Krautheim 2004). As it is unclear whether the
use of antiseptics for preoperative bathing or showering leads to
lower rates of SSIs, a systematic review is justified to guide practice
in this area.
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O B J E C T I V E S
To review the evidence for preoperative bathing or showering with
antiseptics for the prevention of surgical site infections.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All published and unpublished randomised controlled trials
(RCTs) that allocate surgical patients individually, or by cluster,
comparing any antiseptic preparation used for preoperative full
body wash or showering, with non-antiseptic preparations. Quasi-
randomised trials were not included (i.e. trials that allocate treat-
ment by day of the week, medical record number, sequential ad-
mitting order etc.).
Types of participants
Men, women and children undergoing any type of surgery in any
setting.
Types of interventions
Any type of antiseptic solution (any strength, any regimen, at any
time before surgery) used for preoperative tub- or bed-bathing or
showering compared with:
1. non-antiseptic soap;
2. non-antiseptic soap solution;
3. no shower or bath.
Antiseptic solutions were defined as liquid soap products contain-
ing an antimicrobial ingredient such as chlorhexidine, triclosan,
hexachlorophene, povidone-iodine or benzalkoniumchloride. Tri-
als comparing different types of antiseptic with each other would
also be compared if preoperative showering with an antiseptic
showed evidence of benefit.
Types of outcome measures
Primary outcomes
Surgical site infection. (Note: despite development of standardised
criteria for defining SSI, the diagnosis of SSIs continues to vary
between studies. We therefore accepted the definition used by
the original authors to determine the proportion of patients who
develop any SSI before or after discharge from hospital).
Secondary outcomes
1. Mortality (any cause).
2. Allergic reactions (e.g. contact dermatitis, anaphylaxis).
3. Postoperative antibiotic use.
4. Length of hospital stay.
5. Re-admission to hospital.
6. Cost.
7. Other serious infection or infectious complication, such as
septicaemia or septic shock.
8. Postoperative fever higher than 38o C on at least two
occasions more than four hours apart, excluding the day of
surgery.
Secondary outcomes were extracted from trial reports regardless of
whether the primary outcome was reported. We excluded studies
that measured only skin colonisation.
Search methods for identification of studies
Electronic searches
For an outline of the search methods used in the second update
of this review see Appendix 1.
For this third update we searched the following electronic
databases:
• Cochrane Wounds Group Specialised Register (searched 5
November 2010);
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2010, Issue 4);
• Ovid MEDLINE (2008 to November Week 2 2010);
• Ovid MEDLINE (In-process & other Non-Indexed
Citations, November 4, 2010);
• Ovid EMBASE (2008 to 2010 Week 42);
• EBSCO CINAHL (2008 to 5 October 2010).
The following strategy was used to search CENTRAL:
#1 MeSH descriptor Skin explode all trees
#2 MeSH descriptor Antisepsis explode all trees
#3 (#1 AND #2)
#4 skin NEXT antisep*
#5MeSH descriptor Anti-Infective Agents, Local explode all trees
#6 MeSH descriptor Soaps explode all trees
#7 MeSH descriptor Povidone-Iodine explode all trees
#8 MeSH descriptor Iodophors explode all trees
#9 MeSH descriptor Chlorhexidine explode all trees
#10 MeSH descriptor Alcohols explode all trees
#11 iodophor* or povidone-iodine or betadine or chlorhexidine
or triclosan or hexachlorophene or benzalkonium or alcohol or
alcohols or antiseptic* or soap*
#12 MeSH descriptor Disinfectants explode all trees
#13 (#1 AND #12)
#14 skin NEAR/5 disinfect*
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#15 MeSH descriptor Detergents explode all trees
#16 (#1 AND #15)
#17 skin NEAR/5 detergent*
#18 (#3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10
OR #11 OR #13 OR
#14 OR #16 OR #17)
#19 MeSH descriptor Surgical Wound Infection explode all trees
#20 surg* NEAR/5 infection*
#21 surgical NEAR/5 wound*
#22 (postoperative or post-operative) NEAR/5 infection*
#23 MeSH descriptor Preoperative Care explode all trees
#24 (preoperative or pre-operative) NEXT care
#25 MeSH descriptor Perioperative Care explode all trees
#26 (perioperative or peri-operative) NEXT care
#27 (#19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25
OR #26)
#28 MeSH descriptor Baths explode all trees
#29 shower* or bath* or wash* or cleans*
#30 (#28 OR #29)
#31 (#18 AND #27 AND #30)
The search strategies for Ovid MEDLINE, Ovid EMBASE and
EBSCO CINAHL can be found in Appendix 2, Appendix 3 and
Appendix 4 respectively. The Ovid MEDLINE search was com-
bined with the Cochrane Highly Sensitive Search Strategy for
identifying randomised trials in MEDLINE: sensitivity- and pre-
cision-maximizing version (2008 revision); Ovid format (Lefebrve
2009). This filter is published in the Cochrane Handbook for Sys-
tematic Reviews of Interventions, Version 5.0.2 [updated Septem-
ber 2009]; Section 6.4.11. The EMBASE and CINAHL searches
were combined with the trial filters developed by the Scottish In-
tercollegiate Guidelines Network (SIGN) (SIGN 2008). No date
or language restrictions were applied.
Searching other resources
Reference lists of all retrieved articles were searched in order to
identify additional studies. For the original version of the review,
manufacturers of antiseptic products were contacted in order to
obtain any unpublished data.
Data collection and analysis
Selection of studies
Both review authors independently assessed the titles and abstracts
of references identified by the search strategy. Full reports of all
potentially relevant trials were then retrieved for assessment of eli-
gibility based on the inclusion criteria. Reference lists of retrieved
studies were screened to identify further studies, which were also
retrieved. Differences of opinion were settled by consensus or re-
ferral to the editorial base of the Wounds Group.
Data extraction and management
The following data were extracted from each study by both review
authors independently using a piloted data extraction sheet: type
of study, study setting, number of participants, sex, mean age, pre-
disposing risk factors, type of antiseptic solutions, use of prophy-
lactic antibiotics, procedure and timing for full body wash, pe-
riod of community follow-up, all primary and secondary outcome
descriptions and outcome measures reported, including infection
rates and study authors’ conclusions.
Assessment of risk of bias in included studies
Two review authors assessed the quality of eligible trials indepen-
dently. A pre-defined quality assessment form, based on the assess-
ment criteria listed below, was used. Once again, disagreements
between review authors were resolved by consensus or referral to
the editorial base of the Wounds Group. When possible, contact
was made with investigators of included trials to resolve any am-
biguities.
For this update each included study was assessed using the
Cochrane Collaboration tool for assessing risk of bias (Higgins
2008). This tool addresses six specific domains, namely sequence
generation, allocation concealment, blinding, incomplete out-
come data, selective outcome reporting and other issues (e.g. ex-
treme baseline imbalance) (see Appendix 5 for details of criteria
on which the judgement will be based for this review). Blinding
and completeness of outcome data were assessed for each outcome
separately.We completed a risk of bias table for each eligible study.
We presented an assessment of risk of bias using a ’risk of bias
summary figure’, which presents all of the judgments in a cross-
tabulation of study by entry. This display of internal validity in-
dicates the weight the reader may give the results of each study.
We defined high quality trials as those receiving a ’low risk of
bias’ rating for the criterion of allocation concealment (central
computerised randomisation service or sealed opaque envelopes)
and for blinding of outcome assessment.
Data synthesis
Analyses were performed using RevMan 5 software. Relative risks
(RR) and 95% confidence intervals (CI) were calculated for di-
chotomous outcomes, and mean differences (MD) and 95% CI
calculated for continuous outcomes. Results of comparable trials
were pooled using the fixed-effect model and 95% CI. Hetero-
geneity was investigated by calculating the I2 statistic (Higgins
2002). If evidence of significant heterogeneity was identified (i.e.
a value greater than 50%), potential sources of heterogeneity were
explored and a random-effects approach to the analysis under-
taken. A narrative review of eligible studies was conducted where
statistical synthesis of data frommore than one study was not pos-
sible, or considered inappropriate.
One trial used a multi-centre design, but patients were allocated
individually to the treatment or control arm (Rotter 1988). Two
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trials allocated clusters of patients to each intervention (Hayek
1987; Wihlborg 1987). In this review results were not analysed
using the number of clusters as the unit of analysis but analysed
as if the allocation was by individual. This was necessary because
the authors of the trial did not use the cluster as the unit of anal-
ysis. Analysing cluster trials in this way has the potential to over-
estimate the effect of treatment (Mollison 2000).
Subgroup analysis and investigation of heterogeneity
The planned sub-group analyses (one preoperative bath or shower
compared with more than one preoperative bath or shower; and
clean surgery compared with clean contaminated surgery) were
not conducted due to the format of the reported data.
Sensitivity analysis
We included all eligible trials in the initial analysis and carried out
sensitivity analyses to evaluate the effect of trial quality. This was
done by excluding those trials most susceptible to bias based on the
following quality assessment criteria: those with inadequate allo-
cation concealment; or unblinded outcome assessment; or where
blinding of outcome assessment was uncertain.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
For a detailed description of the included studies see
Characteristics of included studies.
Our original search strategy identified 43 articles. Full-text as-
sessment was conducted for 16 potentially eligible papers. Seven
of these papers were excluded from further review because the
studies were not randomised, or were randomised trials evaluating
other interventions (e.g. preoperative scrub solutions), or other
outcomes (e.g. intraoperative wound colonisation) (Ayliffe 1983;
Bergman 1979; Brandberg 1980; Garabaldi 1988; Leigh 1983;
Newsom 1988;Wells 1983). The remaining nine citations referred
to six trials, which reported outcomes for 10,007 participants,
and were included in the review (Byrne 1992; Earnshaw 1989;
Hayek 1987; Randall 1983; Rotter 1988; Wihlborg 1987). The
results of these six trials were reported in nine publications (Byrne
1992; (Byrne 1994, Lynch 1992); Earnshaw 1989; Hayek 1987
(Hayek 1988); Randall 1983; Rotter 1988; Veiga 2008; Wihlborg
1987). Four authors of included trials (Byrne 1992; Earnshaw
1989; Randall 1983;Wihlborg 1987), and one non-included trial
author (Garabaldi 1988), responded to queries about study meth-
ods or requests for additional unpublished information, or both.
In the first update of the review three further trials were identified,
but these did not meet the inclusion criteria for the review, and so
were excluded (Edmiston 2008; Kalanter-Hormozi 2005; Paulson
1993). Details of these can be found in the Characteristics of
excluded studies table. A further search was undertaken when we
conducted the second update of the review to include Risk of Bias
and Summary of findings tables. Four potentially eligible trials
were located, three of these were excluded because either they
were not randomised controlled trials or they did not include the
primary outcome (Enjabert 1984; Kaiser 1988; Veiga 2008). One
trial of 150 participants met the inclusion criteria and was added
to the review (Veiga 2009).
In this third update, our search identified 27 additional records.
Full texts of three, potentially-useful, references were assessed, but
none met the review’s inclusion criteria (Edminson 2010; Eiselt
2009; Jakobsson 2010). Reasons for their exclusion are detailed in
the Characteristics of excluded studies table.
Participants
The age range of the participants in the seven included studies was
nine to 90 years old. The trials enrolled men, women and children
booked for elective surgery.
Byrne 1992 included clean and potentially infected cases but all
other studies were of clean surgery. Two studies included general
surgical patients (Byrne 1992; Hayek 1987); one involved par-
ticipants undergoing general, orthopaedic and vascular surgery
(Rotter 1988); one enrolled participants scheduled for plastic sur-
gical procedures (Veiga 2009) and one included biliary tract, in-
guinal hernia or breast surgery (Wihlborg 1987). The remaining
studies involved only one type of surgery (Earnshaw 1989: vascu-
lar reconstruction; Randall 1983: vasectomy). Participants in the
vasectomy study were day patients (Randall 1983).
Four of the centres in which the studies were conducted were in
the United Kingdom (Byrne 1992; Earnshaw 1989; Hayek 1987;
Randall 1983); one was in Sweden (Wihlborg 1987); one study
was undertaken inBrazil (Veiga 2009); and one included a number
of European centres (eight from Denmark, five from the United
Kingdom, four fromSweden, two fromAustria, and one each from
Germany and Italy) (Rotter 1988).
While Veiga 2009 used CDC definitions for surgical site infec-
tion, all of the other studies included the presence of pus in their
definition of infection. Earnshaw 1989 and Hayek 1987 also in-
cluded patients with severe cellulitis (although there was only such
patient), and Randall 1983 included patients with a discharge of
serous fluid in his definition of infection.
Interventions
There were inconsistencies in both the interventions and the con-
trol procedures between studies. One trial compared a regimen
that included three preoperative washes (Byrne 1992), three tri-
als included a two-wash regimen (Earnshaw 1989; Hayek 1987;
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Rotter 1988), and participants in three trials had only one wash
preoperatively (Randall 1983; Veiga 2009; Wihlborg 1987).
The breakdown of the studies according to timing of bathing was
as follows:
• One wash on admission, a second on the night before
surgery and a third on the morning of surgery (Byrne 1992).
• One wash immediately after admission, and a second on
the day of surgery (Hayek 1987).
• One wash on the day before surgery, and a second on the
day of surgery (Rotter 1988).
• Two washes preoperatively, timing not specified (Earnshaw
1989).
• One wash on the day before surgery only (Wihlborg 1987).
• One wash not more than one hour before surgery (Randall
1983).
• One wash (with two applications of chlorhexidine
detergent) two hours before surgery (Veiga 2009).
Three of the studies had two arms (Byrne 1992; Earnshaw 1989;
Rotter 1988), whilst four had three arms (Hayek 1987; Randall
1983; Veiga 2009; Wihlborg 1987). The breakdown of studies
according to bathing products was as follows:
• 4% chlorhexidine gluconate (Hibiscrub/Riohex) detergent
solution compared with a matching placebo (i.e. the same
detergent without chlorhexidine) (Byrne 1992; Hayek 1987;
Rotter 1988; Veiga 2009).
• 4% chlorhexidine gluconate (Hibiscrub) compared with
bar soap (Earnshaw 1989; Hayek 1987; Randall 1983).
• Chlorhexidine with no shower or bath (Randall 1983;
Veiga 2009; Wihlborg 1987).
• Chlorhexidine full body bathing compared with localised
washing, i.e. restricted to the part of the body to be subjected to
surgery (chlorhexidine used in both arms of trial) (Wihlborg
1987).
Antibiotic prophylaxis was used routinely in only one study
(Earnshaw 1989). In three other studies there was no attempt to
alter the treating surgeons’ usual routine for administering antibi-
otic prophylaxis but, in these studies, the reported rate of prophy-
lactic antibiotic use was low (1% to 15%) (Byrne 1992; Rotter
1988; Wihlborg 1987). One trial excluded patients who were on
antibiotics at the time of surgery but did not control for postoper-
ative antibiotic use, which the trialists said was high (Veiga 2009).
Two studies did not mention whether antibiotics were used before
surgery (Hayek 1987; Randall 1983).
Outcome measures
Primary outcome
The primary outcome measure for this review, the effectiveness of
preoperativewashing or showeringwith an antiseptic in preventing
SSI, was reported in all of the studies (Byrne 1992; Earnshaw1989;
Hayek 1987; Randall 1983; Rotter 1988; Veiga 2009; Wihlborg
1987).
Secondary outcomes
The secondary outcomes of the review were reported as follow:
1. Mortality (any cause) was reported in two studies (Byrne
1992; Earnshaw 1989).
2. Allergic reactions (e.g. contact dermatitis, anaphylaxis) were
reported in two trials (Byrne 1992; Veiga 2009).
3. Postoperative antibiotic use was not reported in any of the
studies.
4. Length of hospital stay was not reported in any of the
studies.
5. Re-admission to hospital was not reported in any of the
studies.
6. Cost was reported in one study (Byrne 1992).
7. Other serious infection or infectious complication, such as
septicaemia or septic shock was not reported in any of the studies.
8. Postoperative fever exceeding 38o C on at least two
occasions more than four hours apart, excluding the day of
surgery, was not reported in any of the studies
Risk of bias in included studies
Two of the seven included studies were assessed as being of high
methodological quality using the assessment criteria described
above (a ’yes’ rating for the criteria of allocation concealment
and blinding of outcome assessment) (Byrne 1992; Rotter 1988).
None of the trials reported how the sample size was calculated.
(See Risk of Bias Figure 1; Figure 2).
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Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Allocation
Generation of random allocation sequence
All studies mentioned a process of randomisation. The method of
generating the random allocation sequence was adequate in some
studies (Byrne 1992; Randall 1983; Rotter 1988; Veiga 2009;
Wihlborg 1987), and unclear in others (Earnshaw 1989; Hayek
1987). In four of the studies, the random sequence was computer-
generated (Byrne 1992; Randall 1983; Rotter 1988; Veiga 2009).
One study used block randomisation in groups of six using com-
puter-generated random numbers (Byrne 1992). A large multi-
centre study used cluster randomisation, whereby randomisation
was carried out for each surgical unit in the study by means of
computer-generated numbers (Rotter 1988). Personal correspon-
dence with authors of two of the studies confirmed that they used
either computer-generated random numbers (Randall 1983), or a
randomisation list (Wihlborg 1987).
Allocation concealment
As with generation of the allocation sequence, concealment of al-
location was adequate in some studies (Byrne 1992; Randall 1983;
Rotter 1988; Wihlborg 1987), and unclear in others (Earnshaw
1989; Hayek 1987; Veiga 2009).
Blinding
Blinding of intervention
Blinding of intervention in three studies was by a double-blind
method (Byrne 1992; Rotter 1988; Veiga 2009). In one study
there was single-blinding of the intervention in two arms of the
study but no blinding in the third arm of the study (Hayek 1987).
In the remaining studies, there was no blinding of intervention
(Earnshaw 1989; Randall 1983; Wihlborg 1987).
Blinding of outcome assessment
Five of the trials blinded outcome assessment (Byrne 1992;
Earnshaw 1989; Hayek 1987; Rotter 1988; Veiga 2009). In one
of the studies there was no blinding of the outcome assessment
(Wihlborg 1987 personal communication). In one study it is un-
clear whether blinding of outcome assessment occurred (Randall
1983).
Incomplete outcome data
In one study analysis by intention-to-treat was not done (Byrne
1992). For all of the other studies it could not be determined
whether analysis by intention-to-treat occurred (Earnshaw 1989;
Hayek 1987; Randall 1983; Rotter 1988; Veiga 2009; Wihlborg
1987).
All of the studies reported the status of all people entered into the
trials. One study reported only one of the 94 patients as lost to fol-
low-up (Randall 1983). Byrne 1992 reported a 99.4% complete-
ness of follow-up. All other studies reported that all patients were
followed-up (Earnshaw 1989; Hayek 1987; Rotter 1988; Veiga
2009;Wihlborg 1987). In one study, 140 patients out of the 2,953
enrolled were withdrawn from the study for several reasons: failure
to have two preoperative showers, not meeting inclusion criteria,
transferring out of unit, or no identification number on patient
protocol (Rotter 1988). Despite this, the study reported on all
remaining patients (n = 2813), resulting in 95.2% completeness
of reporting.
Two authors recorded SSIs during hospitalisation and then fol-
lowed patients for six weeks after hospital discharge (Byrne 1992;
Hayek 1987), Rotter 1988 followed patients for three weeks,
Randall 1983 for seven days, Veiga 2009 for 30 days; Wihlborg
1987 monitored SSIs that occurred in hospital and among those
returning for an outpatient visit, and Earnshaw 1989 reviewed
patients twice weekly until hospital discharge.
Effects of interventions
See:Summary of findings for themain comparisonPreoperative
showeringwith chlorhexidine 4%compared toplacebo;Summary
of findings 2 Chlorhexidine 4% compared with bar soap;
Summary of findings 3 Chlorhexadine 4% compared with no
wash
This review includes outcome data from seven trials with a total of
10,157 participants. Six comparisons were undertaken: chlorhex-
idine 4% versus placebo (Analysis: 01) (Byrne 1992; Hayek 1987;
Rotter 1988;Veiga 2009); chlorhexidine 4%versus bar soap (Anal-
ysis: 02) (Earnshaw 1989; Hayek 1987; Randall 1983); chlorhexi-
dine versus no bath or shower (Analysis: 03) (Randall 1983; Veiga
2009; Wihlborg 1987); whole body wash with chlorhexidine ver-
sus washing only that part of the body to be submitted to surgery
(Analysis: 04) (Wihlborg 1987); more than one wash versus one
wash (Analysis: 05) (Byrne 1992; Hayek 1987; Randall 1983;
Rotter 1988); and one post hoc comparison, individual allocation
versus cluster allocation (Analysis: 06) (Byrne 1992; Earnshaw
1989; Hayek 1987; Randall 1983; Rotter 1988; Wihlborg 1987).
A random-effect meta-analysis was used when significant hetero-
geneity was present (i.e. where the I2 value was greater than 50%).
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Chlorhexidine compared with placebo
This comparison includes four trials of 7791 participants and in-
cludes four outcomes (SSI, allergic reactions, mortality and cost)
(Byrne 1992; Hayek 1987; Rotter 1988; Veiga 2009).
Surgical site infection
Participants in three of the trials had more than one wash (Byrne
1992; Hayek 1987; Rotter 1988); but in the Veiga 2009 trial par-
ticipants had only one shower.Hayek 1987, Rotter 1988 andVeiga
2009 included patients having elective surgery, whereas Byrne
1992 included patients undergoing “clean or potentially infected
surgery”. It should be noted that in the Hayek 1987 trial the
placebo was found to contain antimicrobial properties and was
changed during the study. None of the individual trials found that
washing with chlorhexidine had a statistically significant effect on
SSI. All of the trials were included in the meta-analysis. When
compared with placebo, bathing with chlorhexidine did not result
in a statistically significant reduction in the SSI rate (chlorhexi-
dine 9.1%, placebo 10.0%); the relative risk (RR) was 0.91 (95%
confidence interval (CI) 0.80 to 1.04) (Analysis 1.1).
Surgical site infection - high quality trials
For this outcome we conducted a separate analysis of trials rated
as high quality by the criteria described in the ’Methods of the Re-
view’ section - namely Byrne 1992 and Rotter 1988 - and obtained
a similar result, the RR was 0.95 (95% CI 0.82 to 1.10) (Analysis
1.2). The event rate was 9.3% for the chlorhexidine group and
9.7% for the placebo group.
Mortality (any cause)
One trial in this comparison reportedmortality data (Byrne 1992).
A total of 23 patients died in the study period, but these were not
reported in groups.
Allergic reaction
Two trials included allergic reaction as an outcome (Byrne 1992;
Veiga 2009). No adverse reactions were reported by Veiga 2009.
In the Byrne 1992 study 19 events were reported, nine (0.5%)
in the chlorhexidine group and 10 (0.6%) in the placebo group.
There was no evidence of a statistically significant difference in
allergy rate (RR 0.89, 95% CI 0.36 to 2.19) (Analysis 1.3).
Cost
There was an estimate of cost in one study (Byrne 1992). The
average total cost (based on drug costs, hotel costs, dressing costs
and outpatients’ costs) of patients washing with chlorhexidine was
UK £936 compared with UK £897 when patients washed with a
placebo. Standard deviations were not reported but, according to
the authors, the difference was not statistically significant.
Chlorhexidine compared with bar soap
Three trials compared washing with chlorhexidine with wash-
ing with bar soap (Earnshaw 1989; Hayek 1987; Randall 1983).
These included 1443 participants and reported on two outcomes
(SSI and mortality). Due to small numbers in two of the trials
(Earnshaw 1989; Randall 1983), andmethodological inconsisten-
cies in the Hayek 1987 trial, estimates of effect are imprecise and
need to be interpreted with caution. Heterogeneity was high for
this comparison (P value 0.08, I2 = 60%), so we used a random-ef-
fects model for the meta-analysis. There are two possible explana-
tions for heterogeneity. First, different types of surgery were con-
ducted in each trial; Earnshaw 1989 included patients undergo-
ing vascular reconstruction, while Hayek 1987 included patients
booked for routine elective surgery and Randall 1983 included
only vasectomy patients. Alternatively, a different definition of SSI
was used by Randall 1983, who included patients with a wound
which discharged pus or serous fluid, whereas Earnshaw 1989 and
Hayek 1987 defined SSI as the discharge of pus.
Surgical site infection
Two trials that compared washing with chlorhexidine with wash-
ing with soap found no difference between the treatments in post-
operative SSI rate (Earnshaw1989;Randall 1983). The largest trial
(Hayek 1987), however, reported significantly fewer SSIs when
patients washed preoperatively with chlorhexidine compared with
those who washed with soap (RR 0.70, 95% CI 0.51 to 0.96)
(Analysis 2.1).When results of the three trialswere combined there
was no statistically significant difference (RR 1.02, 95% CI 0.57
to 1.84) (Analysis 2.1), the event rate was 10.9% for chlorhexidine
and 13.6% for bar soap.
Mortality (any cause)
Two patients died in the Earnshaw 1989 trial, but these were not
reported by group.
Chlorhexidine compared with no wash
Three trials compared washing with chlorhexidine with no specific
washing instructions (Randall 1983; Veiga 2009;Wihlborg 1987).
These included 1142 patients and reported on SSI only. There was
significant statistical heterogeneity between the three trials (P value
< 0.03), and clinical heterogeneity (outpatient surgery versus inpa-
tient surgery; different types of included patients). Randall 1983
enrolled patients undergoing vasectomy, Veiga 2009 included pa-
tients having plastic surgery andWihlborg 1987 included patients
undergoing elective surgery of the biliary tract, inguinal hernia or
breast cancer. In addition, Randall 1983 defined SSI as a wound
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which discharged pus or serous fluid, Wihlborg 1987 defined SSI
as the discharge of pus and Veiga 2009 defined SSI using Centers
for Disease Control criteria for wound infection and wound clas-
sification.
Surgical site infection
Randall 1983 found no difference in the postoperative SSI rate
between patients who washed with chlorhexidine compared with
patients who did not wash preoperatively (12/32 (37.5%) patients
in the chlorhexidine group developed an infection compared with
9/32 (28.1%) in the no wash group. In the Veiga 2009 trial, none
of the patients in the no wash group developed a surgical site in-
fection (0%) compared to one (0.2%) in the chlorhexidine group
(RR 3.00; 95% CI 0.13 to 71.92). In the larger trial, Wihlborg
1987 found that a chlorhexidine wash when compared with no
wash resulted in a statistically significant reduction in the num-
ber of patients with a SSI; (9 of the 541 (1.7%) patients in the
chlorhexidine group developed an infection compared with 20
of 437 (4.6%) in the no wash group (RR 0.36; 95% CI 0.17
to 0.79) (Analysis 3.1). Although patients in the no-wash groups
were given no instructions to shower or bathe preoperatively, it is
unclear whether any did so.
Chlorhexidine full wash compared with partial wash
One trial compared washing the whole body with chlorhexidine
with a partial localised wash with chlorhexidine soap (Wihlborg
1987). This trial included 1093 participants and assessed one out-
come; SSI.
Surgical site infection
Data from one trial making this comparison (Wihlborg 1987)
showed a statistically significant reduction in SSIs when whole
body washing (1.7%) was compared with partial localised washing
(4.1%) (RR 0.40, 95% CI 0.19 to 0.85) (Analysis 4.1).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Chlorhexidine 4% compared with bar soap for Surgical patients
Patient or population: surgical patients
Settings:
Intervention: chlorhexidine 4%
Comparison: bar soap
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
bar soap Chlorhexidine 4%
Surgical site infection Study population RR 1.02
(0.57 to 1.84)
1443
(3 studies)
⊕©©©
very low1,2,3
136 per 1000 139 per 1000
(78 to 250)
Medium risk population
128 per 1000 131 per 1000
(73 to 236)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The method of allocation was unclear in some studies and outcome assessment was not blinded.
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2 Heterogeneity between trials was evident; this was most probably due to the different types of surgeries and different definitions used
for infection.
3 95% confidence interval around the pooled estimate of effect includes both 1) no effect and 2) appreciable benefit or appreciable harm.
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Chlorhexidine 4% compared with no wash for surgical patients
Patient or population: surgical patients
Settings: hospital
Intervention: chlorhexidine 4%
Comparison: no wash
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
no wash Chlorhexidine 4%
Surgical site infection
Follow-up: 1 - 3 weeks1
Study population RR 0.82
(0.26 to 2.62)
1142
(3 studies)
⊕©©©
very low2,3,4
56 per 1000 46 per 1000
(15 to 147)
Medium risk population
46 per 1000 38 per 1000
(12 to 121)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Some studies followed patients only until hospital discharge; as the studies were over 20 years old, we have assumed this to be one
week.
2 A number of potential biases existed including inadequate allocation concealment and blinding.1
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3 Heterogeneity between studies was evident; this was most likely due to different types of surgeries, differences in length of follow-up,
varying sample sizes and ways of defining infection.
4 Wide confidence intervals, low event rate.
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D I S C U S S I O N
Widespread use of preoperative antiseptic washing agents to pre-
vent SSI continues. This review summarises trial data from over
10,000 patients, that compared washing with chlorhexidine with
either a placebo solution, or a bar soap, or no preoperative washing
at all. There was no clear evidence that washing with chlorhexi-
dine reduced the incidence of SSI. The results of the review are
strengthened by the heterogeneous nature of the participants; the
trials included men, women and children undergoing a range of
surgeries that were either clean or potentially infected, and un-
dertaken in both inpatient and outpatient settings. These studies
were published over a 26-year period between 1983 and 2009.
The product used in the trials (chlorhexidine 0.4%) remains un-
changed and the quality of the two largest trials (that included
over 6,000 participants) was high, concealing the randomisation
process and blinding the interventions. Both of these trials also
included community follow-up.
One of the limitations of the review was the quality of some of
the studies. Community follow-up was attempted in only four
studies, only one of the authors provided justification for their
sample sizes (Byrne 1992), and in both studies where a cluster
design was used, analysis was conducted as if participants had
been allocated individually. Nonetheless, the high quality trials
and trials where participants were allocated individually, showed
no statistically significant reduction in SSIs when chlorhexidine
was used for preoperative washing.
Only one of the trials provided data for other important out-
comes. Byrne 1992 assessed complications or undesirable effects
attributable to the use of an antiseptic. In this trial patients as-
signed to chlorhexidine use were nomore likely to suffer an adverse
reaction than those assigned to the placebo group. There were
no comparisons with bar soap for this outcome. Byrne 1992 also
assessed the cost of washing with chlorhexidine compared with
placebo and found a non-significant cost reduction in the placebo
group. Costs included length of hospital stay, so, even though the
SSI rate was 1.1% higher in the placebo group, using a placebo
still resulted in an overall cost benefit.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review provides no clear evidence of a benefit in reduced
SSI rates associated with preoperative showering or bathing with
chlorhexidine compared with other wash products. Efforts to re-
duce the incidence of nosocomial SSI should focus on interven-
tions where effect has been demonstrated.
Implications for research
Any future trials designed to assess the effectiveness of chlorhexi-
dine as a preoperative body wash to prevent surgical site infection
should:
• Follow the CONSORT statement when designing and
reporting the trial.
• Conduct a priori sample size calculations based on results of
this review.
• Document preoperative and intra-operative antibiotic use.
• Include a follow-period of at least 4 weeks.
• Include clinically-relevant secondary endpoints (mortality,
adverse effects, cost effectiveness, length of hospital stay).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Byrne 1992
Methods RCT.
Power calculation: yes.
Follow-up period: 6 weeks after discharge.
Participants 3733 patients undergoing elective or potentially contaminated surgery.
Exclusion criteria: patients undergoing day surgery, emergency surgery, re-operation or
contaminated surgery and those unable to comply with the washing procedure, or with a
known allergy to chlorhexidine or having more than the standard prophylactic antibiotic
regimen.
Baseline comparability: age, sex, type of surgery, ASEPSIS score
Interventions All patients showered 3 times (on admission, the night before surgery and the morning
of surgery) using 50 ml of either:
Group 1: 4% chlorhexidine, or
Group 2: a placebo.
Written instructions were provided to all participants.
Outcomes Primary outcome:
Wound infection was defined as discharge of pus from a wound for inpatients or outpa-
tients, or an ASEPSIS score greater than 10.
Group 1: 256/1754 (14.6%);
Group 2: 272/1735 (15.7%).
Secondary outcomes:
Death, allergic reactions, cost.
Notes Data were extracted from 3 papers reporting results from 1 study (see Lynch 1992 &
Byrne 1994). There wereminor discrepancies in numbers reported between the 3 studies.
The version reported is the definitive study (personal correspondence with author). The
abstract stated there were 1753 patients in the placebo group but this should have been
1735
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was performed in blocks of
6. Randomisation in each group of 6 was
by computer-generated random numbers
Allocation concealment (selection bias) Low risk Personal communication with author. Al-
location in sealed envelopes
22Preoperative bathing or showering with skin antiseptics to prevent surgical site infection (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Byrne 1992 (Continued)
Blinding (performance bias and detection
bias)
Investigator and participant
Low risk 2 bottles of either 4% chlorhexidine de-
tergent solution or a physically-identical
placebo detergent were given to the patient.
Neither the investigators nor the patient
were aware of the allocation.
Outcome blinding was not specifically
mentioned, however, it seems likely that
those assessing infection status would have
been unaware of the allocation
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk Outcome assessment blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of 3733 patients randomised, 244 (6.5%)
were excluded from the outcome analysis.
The majority of these, 219 (5.9%) were
because the operation was cancelled after
randomisation. 4 patients in the chlorhex-
idine group and 9 patients in the control
group were excluded for protocol viola-
tions. However, as these numbers are ex-
tremely small (0.4% of those randomised),
it is unlikely that results were compromised
Selective reporting (reporting bias) Low risk The study reported on all of the stated out-
comes.
Other bias Low risk The trial was supported by ICI Pharmaceu-
ticals. However, as results did not support
the use of chlorhexidine, it is unlikely that
results were compromised
Earnshaw 1989
Methods RCT.
Power calculation: no.
Follow-up period: until hospital discharge.
Participants 66 patients undergoing vascular reconstruction surgery.
Exclusion: none reported.
Baseline comparability: stated that groups were similar, no data
Interventions All patients had 2 baths.
Group 1: painted entire body with undiluted 4% chlorhexidine followed by rinsing in
the bath. Precise instructions given;
Group 2: non-medicated soap used. No specific instructions provided
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Earnshaw 1989 (Continued)
Outcomes Primary outcome:
Wound infection was defined as discharge of pus from a wound; 1 patient with severe
cellulitis was also included.
Group 1: 8/31 (26%);
Group 2: 4/35, (11.4%).
Secondary outcome:
Death.
Notes Different washing information provided to participants in each group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described. Investigator contacted - no
further information available
Allocation concealment (selection bias) Unclear risk Not described. Investigator contacted - no
further information available
Blinding (performance bias and detection
bias)
Investigator and participant
High risk Both the investigator and the participant
were aware of the allocation.
Postoperatively wounds were reviewed
blind until patients left hospital
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk Outcome assessment blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Results were available for all those enrolled.
No drop outs or exclusions were described
Selective reporting (reporting bias) Low risk The study reported on wound infection.
A number of post hoc analyses were also
conducted
Other bias High risk Baseline data tables were not provided but
the author stated that “clinical details of the
two groups were similar”.
Different washing information provided to
participants in each group.
Hibiscrub (chlorhexidine) was provided by
ICI. However, as results favoured the use
of soap, it is unlikely that the involvement
of the pharmaceutical company influenced
results
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Hayek 1987
Methods Cluster RCT.
Power calculation: no.
Follow-up period: until hospital discharge.
Participants 2015 patients undergoing routine surgery.
Exclusion: those receiving antibiotics or with an existing infection.
Baseline comparability: age, sex, preoperative skin preparation, wound classification,
proportion who washed their hair
Interventions All patients had either a shower or bath on the day before andmorning of their operation.
Group 1: chlorhexidine 4%. Instruction card for washing provided.
Group 2: placebo. Instruction card for washing provided (5 months into the study, the
placebo was found to have antimicrobial properties and was changed).
Group 3: bar soap. No washing instructions provided.
Outcomes Primary outcome:
Wound infection was defined as either discharge of pus from a wound, or erythema, or
swelling considered to be greater than expected.
Group 1: 62/689 (9.0%);
Group 2: 83/700 (11.7%);
Group 3: 80/626 (12.8%).
Notes Data were extracted from 2 papers reporting results from 1 study (Hayek 1988)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding (performance bias and detection
bias)
Investigator and participant
High risk 3 arms to the study. ”None of the ward staff
or those assessing the wounds were aware of
whether placebo or active compound was
being used as these were issued in identical
coded sachets, though no form of double
blind was possible for the bar soap group“
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk Outcome assessment blinded.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk It appears from the text that results were
available from all patients who entered the
study. However, as patients were followed
up for 6 weeks postoperatively; it seems un-
usual that none were lost to follow-up
25Preoperative bathing or showering with skin antiseptics to prevent surgical site infection (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hayek 1987 (Continued)
Selective reporting (reporting bias) Low risk All data reported.
Other bias High risk No baseline data presented. The authors
state that ”The three groups are comparable
except for one interesting facet; only 14%
washed their hair with bar soap against
28% with either of the liquids.
Specific washing instructions were pro-
vided to the chlorhexidine and placebo
groups but not to the bar soap group.
5 months into the study, the placebo was
found to have antimicrobial properties and
was changed.
It is unclear how this large study was
funded. No competing interests were de-
clared
Randall 1983
Methods RCT.
Power calculation: no.
Follow-up period: 1 week after discharge.
Participants 94 patients undergoing vasectomy.
Exclusion: none stated.
Baseline comparability: none stated.
Interventions Group 1: 1 preoperative shower with chlorhexidine 4%,
Group 2: 1 shower with normal soap.
Group 3: no shower.
Outcomes Primary outcome:
Wound infection was defined as discharging either purulent or serous fluid.
Group 1: 12/32 (37.5%);
Group 2: 10/30 (33.3%);
Group 3: 9/32 (28.1%).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Personal correspondence with study au-
thors confirmed that trialists used com-
puter-generated random numbers
Allocation concealment (selection bias) Unclear risk Method not described.
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Randall 1983 (Continued)
Blinding (performance bias and detection
bias)
Investigator and participant
High risk Blinding of the intervention was not possi-
ble.
Blinding (performance bias and detection
bias)
Outcome assessor
Unclear risk It is unclear if outcome assessment was
blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All but 1 enrolled patient were assessed 7
days postoperatively; 83 returned to the
ward, 10 were contacted at home and 1 was
lost to follow-up (it is unclear which group
this patient was in); results were presented
for the total number enrolled
Selective reporting (reporting bias) Low risk All data reported.
Other bias Low risk No baseline data presented.
No competing interests declared.
Rotter 1988
Methods Cluster RCT.
Power calculation: no.
Follow-up period: 3 weeks after discharge.
Participants 2953 patients undergoing elective clean surgery.
Exclusion: patients with a temperature of 37.5oC on the day of or day before surgery,
infection remote from operation site, antibiotics given within 7 days prior to surgery for
infection, incarcerated inguinal hernia, radical mastectomy.
Baseline comparability: age, sex, type of surgery, antibiotic prophylaxis, hair washed, hair
removal method, wound drainage
Interventions All patients had 2 showers;1 the day before surgery and 1 on the day of surgery.
Group 1: used 50 ml of chlorhexidine 4% for each shower;
Group 2: placebo.
Special application instructions were provided to all participants
Outcomes Primary outcome:
Wound infection was defined in the report as “inflammation of the surgical wound
with discharge of pus, spontaneous and/or after surgical intervention that occurs during
hospitalisation or during routine follow-up”
Group 1: 37/1413 (2.6%);
Group 2: 33/1400 (2.4%).
Notes
Risk of bias
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Rotter 1988 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was carried out for each
surgical unit by means of computer-gener-
ated patient trial numbers
Allocation concealment (selection bias) Low risk Bottles of solution were contained in boxes
of 10, each holding 5 chlorhexidine and
5 placebo in random sequence. Unless the
code was broken, it was impossible to know
which preparation the patient had used
Blinding (performance bias and detection
bias)
Investigator and participant
Low risk Neither patients nor investigators were
aware of group allocation
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk Outcome assessment was by routine
surveillance methods employed by individ-
ual hospitals (infection control nurse or
surgeon). They were unaware of group al-
location
Incomplete outcome data (attrition bias)
All outcomes
Low risk 140 (4.7%) patients were withdrawn af-
ter randomisation either because the pa-
tient was not operated on (62 patients),
had had 1 bath only (26), operation not
stated ’clean’ (14) or had a current infec-
tion (38). The withdrawals were evenly
distributed between the chlorhexidine and
placebo groups
Selective reporting (reporting bias) Low risk All data reported.
Other bias Low risk ICI supplied the bathing materials. How-
ever, as results favoured the placebo group,
this is unlikely to have affected results
Veiga 2009
Methods RCT.
Power calculation: no.
Follow-up period: 30 days.
Participants Adult patients, scheduled for plastic surgery at a University-affiliated hospital in Brazil
Exclusions: hypersensitivity to chlorhexidine, presence of skin lesions, antibiotic use at
time of surgery, diabetes, heavy smoking, immunosuppression
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Veiga 2009 (Continued)
Interventions Group 1: shower with liquid-based detergent containing 4% chlorhexidine;
Group 2: shower with the same liquid-based detergent, without chlorhexidine;
Group 3: no preoperative showering instructions were given.
Patients in Groups 1 and 2 were asked to rinse thoroughly, lather with the antiseptic,
rinse, lather and rinse again
Outcomes Primary outcome:
Surgical site infection (defined using Centers for Disease Control criteria for wound
infection and wound classification)
Group 1: 1/50 (2%);
Group 2: 1/50 (2%);
Group 3: 0/50 (0%).
Secondary outcome:
Adverse reactions: no adverse reactions were reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding (performance bias and detection
bias)
Investigator and participant
Low risk Surgeons and patients were all blinded to
the allocation group
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk Outcome assessors and microbiologists
were all blinded to the allocation group
Incomplete outcome data (attrition bias)
All outcomes
Low risk All patients were followed for the nomi-
nated 30 days.
Selective reporting (reporting bias) Low risk Expected outcomes were reported.
Other bias Low risk The placebo solution was provided by Rio-
quimica Industria Farmaceutica, themanu-
facturer of the intervention product. How-
ever, as results in different groups were sim-
ilar, this is unlikely to have affected results
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Wihlborg 1987
Methods RCT.
Power calculation: no.
Follow-up period: until hospital discharge.
Participants 1530 patients undergoing elective surgery of the biliary tract, inguinal hernia and breast
cancer.
Exclusion: none stated.
Baseline comparability: age, duration of surgery > 2 hours, steroids, diabetes, malignancy
(other than breast cancer), type of surgery
Interventions Group 1: patients washed their entire body with chlorhexidine on the day before surgery
using 2 consecutive applications followed by rinsing under the shower;
Group 2: washed only that part of the body to be submitted to surgery with chlorhexidine
soap;
Group 3: No chlorhexidine wash.
Outcomes Primary outcome:
Wound infectionwas defined as a definite collection of pus emptying itself spontaneously
or after incision:
Group 1: 9/541 (1.7%);
Group 2: 23/552 (4.2%);
Group 3: 20/437 (4.6).
Notes This study was conducted over a 7 year period from 1978 to 1984.
It was unclear from the text whether patients allocated to the ’no chlorhexidine wash’
group had any preoperative shower. 3 patients died and were not included in the analysis.
Strength of wash solution was not stated.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Personal correspondence with study au-
thors confirmed that they used a randomi-
sation list
Allocation concealment (selection bias) Low risk Patients were randomly allocated to 1 of
3 wards in which different preoperative
preparation schedules were used. The au-
thor states that “The randomisation was
done by the Chief surgeon in such a way
that he did not know the identity of the
patients allocated to each ward.”
Blinding (performance bias and detection
bias)
Investigator and participant
High risk Blinding would have been impossible be-
cause of the allocation method
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Wihlborg 1987 (Continued)
Blinding (performance bias and detection
bias)
Outcome assessor
High risk Outcome assessment was not blinded (per-
sonal correspondence with study authors)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3 patients died in the few days following
surgery, these were not identified by group
Selective reporting (reporting bias) Low risk All data reported.
Other bias Unclear risk Baseline risk factors were similar across
groups.
No competing interests declared.
Abbreviations
> = more than
ASEPSIS = a scoring method for postoperative wounds infections for use in clinical trials of antibiotic prophylaxis (Wilson 1986).
RCT = randomised controlled trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ayliffe 1983 Not a randomised controlled trial.
Bergman 1979 No data on wound infection. Not a randomised controlled trial
Brandberg 1980 Not a randomised controlled trial. Local wash versus full body wash with chlorhexidine
Edminson 2010 Not a clinical trial.
Edmiston 2008 Healthy volunteers used to compare skin concentration levels of chlorhexidine gluconate (CHG) following
washing with various CHG products
Eiselt 2009 Not a randomised controlled trial. Used a pre and post intervention design
Enjabert 1984 Not a randomised controlled trial.
Garabaldi 1988 No no-antiseptic group. Did not report infection rates by group
Jakobsson 2010 Systematic review.
Kaiser 1988 Did not report infection rates by group.
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(Continued)
Kalanter-Hormozi 2005 Patients in both groups showered with water. The trial compared methods of skin preparation prior to
surgery
Leigh 1983 Not a randomised controlled trial.
Newsom 1988 Not a randomised controlled trial. Patients were allocated by month
Paulson 1993 Assessed reduction in microbial loads in healthy volunteers.
Veiga 2008 Assessed the influence of povidone-iodine preoperative showers on skin colonization. Rates of wound
infection not reported
Wells 1983 Not a randomised controlled trial. Did not report infection rates by group
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D A T A A N D A N A L Y S E S
Comparison 1. Chlorhexidine 4% versus placebo
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Surgical site infection 4 7791 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.80, 1.04]
2 Surgical site infection (high
quality studies)
2 6302 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.82, 1.10]
3 Allergic reaction 2 3589 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.36, 2.19]
Comparison 2. Chlorhexidine 4% versus bar soap
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Surgical site infection 3 1443 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.57, 1.84]
Comparison 3. Chlorhexadine 4% versus no wash
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Surgical site infection 3 1142 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.26, 2.62]
Comparison 4. Chlorhexidine full wash versus partial wash
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Surgical site infection 1 1093 Risk Ratio (M-H, Fixed, 95% CI) 0.40 [0.19, 0.85]
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Analysis 1.1. Comparison 1 Chlorhexidine 4% versus placebo, Outcome 1 Surgical site infection.
Review: Preoperative bathing or showering with skin antiseptics to prevent surgical site infection
Comparison: 1 Chlorhexidine 4% versus placebo
Outcome: 1 Surgical site infection
Study or subgroup Chlorhexidine Placebo Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Byrne 1992 256/1754 272/1735 70.1 % 0.93 [ 0.80, 1.09 ]
Hayek 1987 62/689 83/700 21.1 % 0.76 [ 0.56, 1.04 ]
Rotter 1988 37/1413 33/1400 8.5 % 1.11 [ 0.70, 1.77 ]
Veiga 2009 1/50 1/50 0.3 % 1.00 [ 0.06, 15.55 ]
Total (95% CI) 3906 3885 100.0 % 0.91 [ 0.80, 1.04 ]
Total events: 356 (Chlorhexidine), 389 (Placebo)
Heterogeneity: Chi2 = 2.10, df = 3 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 1.38 (P = 0.17)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours CHX Favours placebo
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Analysis 1.2. Comparison 1 Chlorhexidine 4% versus placebo, Outcome 2 Surgical site infection (high
quality studies).
Review: Preoperative bathing or showering with skin antiseptics to prevent surgical site infection
Comparison: 1 Chlorhexidine 4% versus placebo
Outcome: 2 Surgical site infection (high quality studies)
Study or subgroup Chlorhexidine 4% Placebo Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Byrne 1992 256/1754 272/1735 89.2 % 0.93 [ 0.80, 1.09 ]
Rotter 1988 37/1413 33/1400 10.8 % 1.11 [ 0.70, 1.77 ]
Total (95% CI) 3167 3135 100.0 % 0.95 [ 0.82, 1.10 ]
Total events: 293 (Chlorhexidine 4%), 305 (Placebo)
Heterogeneity: Chi2 = 0.50, df = 1 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours CHX Favours placebo
Analysis 1.3. Comparison 1 Chlorhexidine 4% versus placebo, Outcome 3 Allergic reaction.
Review: Preoperative bathing or showering with skin antiseptics to prevent surgical site infection
Comparison: 1 Chlorhexidine 4% versus placebo
Outcome: 3 Allergic reaction
Study or subgroup Chlorhexidine 4% placebo Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Byrne 1992 9/1754 10/1735 100.0 % 0.89 [ 0.36, 2.19 ]
Veiga 2009 0/50 0/50 Not estimable
Total (95% CI) 1804 1785 100.0 % 0.89 [ 0.36, 2.19 ]
Total events: 9 (Chlorhexidine 4%), 10 (placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours CHX Favours Placebo
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Analysis 2.1. Comparison 2 Chlorhexidine 4% versus bar soap, Outcome 1 Surgical site infection.
Review: Preoperative bathing or showering with skin antiseptics to prevent surgical site infection
Comparison: 2 Chlorhexidine 4% versus bar soap
Outcome: 1 Surgical site infection
Study or subgroup Chlorhexidine 4% Bar soap Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Earnshaw 1989 8/31 4/35 19.0 % 2.26 [ 0.75, 6.77 ]
Hayek 1987 62/689 80/626 48.6 % 0.70 [ 0.51, 0.96 ]
Randall 1983 12/32 10/30 32.4 % 1.13 [ 0.57, 2.21 ]
Total (95% CI) 752 691 100.0 % 1.02 [ 0.57, 1.84 ]
Total events: 82 (Chlorhexidine 4%), 94 (Bar soap)
Heterogeneity: Tau2 = 0.16; Chi2 = 5.02, df = 2 (P = 0.08); I2 =60%
Test for overall effect: Z = 0.07 (P = 0.94)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours CHX Favours bar soap
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Analysis 3.1. Comparison 3 Chlorhexadine 4% versus no wash, Outcome 1 Surgical site infection.
Review: Preoperative bathing or showering with skin antiseptics to prevent surgical site infection
Comparison: 3 Chlorhexadine 4% versus no wash
Outcome: 1 Surgical site infection
Study or subgroup Chlorhexadine 4% No wash Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Randall 1983 12/32 9/32 45.4 % 1.33 [ 0.65, 2.72 ]
Veiga 2009 1/50 0/50 10.7 % 3.00 [ 0.13, 71.92 ]
Wihlborg 1987 9/541 20/437 43.9 % 0.36 [ 0.17, 0.79 ]
Total (95% CI) 623 519 100.0 % 0.82 [ 0.26, 2.62 ]
Total events: 22 (Chlorhexadine 4%), 29 (No wash)
Heterogeneity: Tau2 = 0.64; Chi2 = 6.77, df = 2 (P = 0.03); I2 =70%
Test for overall effect: Z = 0.33 (P = 0.74)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours CHX Favours no wash
Analysis 4.1. Comparison 4 Chlorhexidine full wash versus partial wash, Outcome 1 Surgical site infection.
Review: Preoperative bathing or showering with skin antiseptics to prevent surgical site infection
Comparison: 4 Chlorhexidine full wash versus partial wash
Outcome: 1 Surgical site infection
Study or subgroup CHX full wash CHX partial wash Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wihlborg 1987 9/541 23/552 100.0 % 0.40 [ 0.19, 0.85 ]
Total (95% CI) 541 552 100.0 % 0.40 [ 0.19, 0.85 ]
Total events: 9 (CHX full wash), 23 (CHX partial wash)
Heterogeneity: not applicable
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours full wash Favours partial wash
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A P P E N D I C E S
Appendix 1. Search strategy for the second review update - 2009
For the second update we searched the following electronic databases:
• Cochrane Wounds Group Specialised Register (Searched 6 March 2009);
• The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 1, 2009);
• Ovid MEDLINE (1950 to February Week 4 2009);
• Ovid EMBASE (1980 to 2009 Week 09);
• EBSCO CINAHL (1982 to February Week 4 2009).
The following strategy was used to search CENTRAL:
#1 MeSH descriptor Skin explode all trees
#2 MeSH descriptor Antisepsis explode all trees
#3 (#1 AND #2)
#4 skin NEXT antisep*
#5 MeSH descriptor Anti-Infective Agents, Local explode all trees
#6 MeSH descriptor Soaps explode all trees
#7 MeSH descriptor Povidone-Iodine explode all trees
#8 MeSH descriptor Iodophors explode all trees
#9 MeSH descriptor Chlorhexidine explode all trees
#10 MeSH descriptor Alcohols explode all trees
#11 iodophor* or povidone-iodine or betadine or chlorhexidine or triclosan or hexachlorophene or benzalkonium or alcohol or alcohols
or antiseptic* or soap*
#12 MeSH descriptor Disinfectants explode all trees
#13 (#1 AND #12)
#14 skin NEAR/5 disinfect*
#15 MeSH descriptor Detergents explode all trees
#16 (#1 AND #15)
#17 skin NEAR/5 detergent*
#18 (#3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #13 OR
#14 OR #16 OR #17)
#19 MeSH descriptor Surgical Wound Infection explode all trees
#20 surg* NEAR/5 infection*
#21 surgical NEAR/5 wound*
#22 (postoperative or post-operative) NEAR/5 infection*
#23 MeSH descriptor Preoperative Care explode all trees
#24 (preoperative or pre-operative) NEXT care
#25 MeSH descriptor Perioperative Care explode all trees
#26 (perioperative or peri-operative) NEXT care
#27 (#19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26)
#28 MeSH descriptor Baths explode all trees
#29 shower* or bath* or wash* or cleans*
#30 (#28 OR #29)
#31 (#18 AND #27 AND #30)
The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL can be found in Appendix 2, Appendix 3 and
Appendix 4 respectively. TheOvidMEDLINE search was combined with the Cochrane Highly Sensitive Search Strategy for identifying
randomised trials in MEDLINE: sensitivity- and precision-maximizing version (2008 revision); Ovid format (Lefebrve 2008). The
EMBASE and CINAHL searches were combined with the trial filters developed by the Scottish Intercollegiate Guidelines Network
(SIGN) (SIGN 2008). No date or language restrictions were applied.
Searching other resources
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Reference lists of all retrieved articles were searched for additional studies. Manufacturers of antiseptic products were contacted in order
to obtain any unpublished data.
Appendix 2. Ovid MEDLINE search strategy
1 exp Skin/
2 exp Antisepsis/
3 and/1-2
4 skin antisep*.tw.
5 exp Anti-Infective Agents, Local/
6 exp Soaps/
7 exp Povidone-Iodine/
8 exp Iodophors/
9 exp Chlorhexidine/
10 exp Alcohols/
11 (iodophor* or povidone-iodine or betadine or chlorhexidine or triclosan or hexachlorophene or benzalkonium or alcohol*1 or
antiseptic* or soap*).tw.
12 exp Disinfectants/
13 1 and 12
14 (skin adj5 disinfect*).tw.
15 exp Detergents/
16 1 and 15
17 (skin adj5 detergent*).tw.
18 or/3-11,13-14,16-17
19 exp Surgical Wound Infection/
20 (surgical adj5 infection*).tw.
21 (surgical adj5 wound*).tw.
22 ((post-operative or postoperative) adj5 wound infection*).tw.
23 exp Preoperative Care/
24 ((preoperative or pre-operative) adj care).tw.
25 exp Perioperative Care/
26 ((perioperative or peri-operative) adj care).tw.
27 or/19-26
28 exp Baths/
29 (shower* or bath* or wash* or cleans*).tw.
30 or/28-29
31 18 and 27 and 30
Appendix 3. Ovid EMBASE search strategy
1 exp Skin/
2 exp Antisepsis/
3 1 and 2
4 skin antisep*.tw.
5 exp Antiinfective Agent/
6 exp Soap/
7 exp Povidone Iodine/
8 exp Iodophor/
9 exp Chlorhexidine/
10 exp Alcohol/
11 (iodophor* or povidone-iodine or betadine or chlorhexidine or triclosan or hexachlorophene or benzalkonium or alcohol*1 or
antiseptic* or soap*).tw.
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12 exp Disinfectant Agent/
13 1 and 12
14 (skin adj5 disinfect*).tw.
15 exp Detergents/
16 1 and 15
17 (skin adj5 detergent*).tw.
18 or/3-11,13-14,16-17
19 exp Surgical Infection/
20 (surgical adj5 infection*).tw.
21 (surgical adj5 wound*).tw.
22 ((post-operative or postoperative) adj5 wound infection*).tw.
23 exp Preoperative Care/
24 ((preoperative or pre-operative) adj care).tw.
25 exp Perioperative Care/
26 ((perioperative or peri-operative) adj care).tw.
27 or/19-26
28 exp Bath/
29 (shower* or bath* or wash* or cleans*).tw.
30 or/28-29
31 18 and 27 and 30
Appendix 4. EBSCO CINAHL search strategy
S29 S15 and S25 and S28
S28 S26 or S27
S27 TI ( shower* or bath* or wash* or cleans* ) or AB ( shower* or bath* or wash* or cleans* )
S26 (MH “Bathing and Baths”)
S25 S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24
S24 TI ( perioperative care or peri-operative care ) or AB (perioperative care or peri-operative care )
S23 (MH “Perioperative Care+”)
S22 TI ( pre-operative care or preoperative care ) or AB ( pre-operative care or preoperative care )
S21 (MH “Preoperative Care+”)
S20 TI post-operative wound infection* or AB post-operative wound infection*
S19 TI postoperative wound infection* or AB postoperative wound infection*
S18 TI surgical N5 wound* or AB surgical N5 wound*
S17 TI surgical N5 infection* or AB surgical N5 infection*
S16 (MH “Surgical Wound Infection”)
S15 S1 or S2 or S3 or S4 or S5 or S6 or S9 or S11 or S12 or S13 or S14
S14 (MH “Skin Preparation, Surgical”)
S13 TI skin N5 antisep* or AB skin N5 antisep*
S12 TI skin N5 disinfect* or AB skin N5 disinfect*
S11 S7 and S10
S10 (MH “Disinfectants”)
S9 S7 and S8
S8 (MH “Detergents+”)
S7 (MH “Skin+”)
S6 TI ( iodophor* or povidone-iodine or betadine or chlorhexidine or triclosan or hexachlorophene or benzalkonium or alcohol* or
antiseptic* or soap*)
and AB (iodophor* or povidone-iodine or betadine or chlorhexidine or triclosan or hexachlorophene or benzalkonium or alcohol* or
antiseptic* or soap* )
S5 (MH “Alcohols+”)
S4 (MH “Chlorhexidine”)
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S3 (MH “Povidone-Iodine”)
S2 (MH “Soaps”)
S1 (MH “Antiinfective Agents, Local+”)
Appendix 5. Risk of bias assessment definitions
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
Insufficient information about the sequence generation process to permit judgement of low or high risk of bias.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.
High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: using an open random allocation schedule (e.g. a list of randomnumbers); assignment envelopes were usedwithout appropriate
safeguards (e.g. if envelopes were unsealed or non opaque or not sequentially numbered); alternation or rotation; date of birth; case
record number; any other explicitly unconcealed procedure.
Unclear
Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not
described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described,
but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
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3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others unlikely to introduce bias.
High risk of bias
Any one of the following.
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
Any one of the following.
• Insufficient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following.
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing
bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a
clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
Any one of the following.
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce
clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes enough to induce clinically relevant bias in observed effect size.
• ‘As-treated’ analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
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Unclear
Any one of the following.
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated,
no reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Any of the following.
• The study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes that are of interest in the
review have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were pre-specified (convincing text of this nature may be uncommon)
High risk of bias
Any one of the following.
• Not all of the study’s pre-specified primary outcomes have been reported.
• One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that
were not pre-specified.
• One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as
an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• had extreme baseline imbalance; or
• has been claimed to have been fraudulent; or
• had some other problem.
Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or
• insufficient rationale or evidence that an identified problem will introduce bias.
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F E E D B A C K
Molnlycke feedback
Summary
A detailed letter was received from Mölynlycke Health Care along with comments from a statistical consultant. Responses to the
feedback are detailed below.
Reply
Response of J Webster and S Osborne to Comments received from Mölynlycke Healthcare
Firstly we would like to thank Mölynlycke Healthcare and Mr P N Lee for submitting comments and for helping to improve the
contents of the Cochrane Library.
We have carefully considered the Comments made and respond to each individually below; we also consulted with Gill Worthy, recently
appointed Statistical Editor of the Cochrane Wounds Group in compiling our response.
In summary whilst on reflection we feel that several of the points raised have merit and we have amended the review accordingly
(by amending the conclusion to “no clear evidence of benefit”, by removing the subgroup analyses, and by not synthesising the data
from the “no wash” comparison) we do not agree with many of the points raised, including several of those raised in the letter from
Mölynlycke.
Detailed Responses to Letter from Milt Hinsch, Technical Services Director, Mölynlycke Healthcare, dated 30 August 2006.
“the conclusion [of the review] is inaccurate”
We agree that the conclusion that there is “evidence of no benefit for preoperative showering or bathing with chlorhexidine…” is badly
worded and in the next update of the Library this has been changed to read “no clear evidence of benefit for preoperative showering or
bathing with chlorhexidine over other wash products”.
“in our view, the erroneous conclusion was reached by reliance on data of poor quality and diversity, and statistical analysis errors and
omissions. For example the study states that antibiotic prophylaxis routinely was used in Earnshaw study (n = 66), but the antibiotic
prophylaxis was not administered using a standardized protocol”
The quality of the many of the studies reviewed was poor and this was clearly acknowledged in the review (e.g. Discussion, paragraph
2) and is typical of research quality in many areas of medical and health care. Unfortunately reviewers can only deal with the data that
exists and this is frequently different from the data one would wish to have. Nevertheless, it is highly worthwhile to review even poor
quality data as it allows identification of unanswered research questions.
As you have not referenced specifics, we are not sure what you mean by statistical analysis errors and omissions. This statement does
not reflect the critique of the review made by your statistician, Mr Lee who did not highlight major statistical analysis errors and
omissions. We do not understand the point being made about the Earnshaw study nor how you think this affected the results and
conclusions. All participants in the Earnshaw study received antibiotic prophylaxis irrespective of which arm they were allocated to and
therefore no bias is introduced as both arms received the same co-interventions. They did in fact receive standardized prophylaxis, viz.
3 perioperative doses of intravenous amoxicillin/clavulanic acid (or erythromycin in the case of sensitivity to the former). Since many
patients do receive antibiotic prophylaxis in real life, inclusion of this study, if anything, increases external validity.
“in the Byrne (n = 3733) , Rotter (n = 2813), and Wihlborg (n = 1530) studies the prophylaxis rate was only 1-15%. Hayek (n = 1989)
and Randall (n = 94) studies did not mention antibiotic usage. One cannot pool these study patients when it is known that antibiotic
prophylaxis can have an effect on surgical site infections (SSI)”.
The decision about which studies are pooled together is a matter of judgment, not fact. Byrne, Hayek and Rotter were pooled together
and the amount of statistical heterogeneity was low at only 4.6%. There was more heterogeneity evident when Earnshaw, Hayek and
Randall were pooled (60%) and therefore a more conservative random-effects model was applied, which takes account of between-study
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as well as within-study variance. Pooling studies which may have different antibiotic usage rates is not “wrong” nor does it introduce
bias, since both arms within trials were treated the same; the only impact may be to reduce precision.
“…the omission of the SSI rate for the different types of surgeries at each institution makes it impossible to understand the significance
of the data. A lower SSI rate requires a greater number of subjects to discern the differences between antiseptic and placebo. The placebo
effect needs better explanation, because review of the clinical outcomes of SSI for the placebo controlled studies shows that the SSI rate
for placebo ranges from 2.4 to 33.3%. The great variation in the SSI rate for placebo calls into question the sensitivity of the method
in the hands of the authors and the ability of the method to detect differences between antiseptic and placebo”.
Again, if we understand the point being made here correctly, it is the same one as in the previous paragraph, and our response is the
same; whilst there may be variation in the baseline infection rates, pooling these studies does not introduce bias and does not therefore
threaten internal validity. The rates quoted are not placebo rates since the 33.3% figure relates to the “shower with normal soap” arm
of the Randall study. Furthermore we have reported a relative measure of outcome rather than absolute differences (which are more
greatly affected by variations in baseline event rates).
“…many of the studies are underpowered to detect differences between antiseptic and placebo…Few of the studies provided information
about calculation of sample size. For this reason it appears that they pooled data from multiple references to try and provide a sufficient
sample size to draw inferences of effect”.
This paragraph succinctly explains the whole rationale of meta-analysis.
Response of J Webster and S Osborne to Comments received from Mr PN Lee (Independent Statistician) forwarded by
Mölynlycke Healthcare
Much of Mr Lee’s 15 page document is merely a description of the review so we will confine our response to his substantive criticisms:
“It should be noted that in theHayek 1987 study the placebo used was found, 5months into the 2 year study, to have some antimicrobial
activity and was subsequently changed… in the Cochrane review, both the discussion on chlorhexidine vs bar soap and the detail of
the characteristics of the Hayek study wrongly state that the soap, and not the placebo, originally used… was changed”. (p3)
Thank you for spotting this error. We have amended this and drawn attention to it, although it does not materially change anything
and we cannot amend the analysis as we do not know how many participants were affected.
“…it certainly seems that many of the studies will be considerably underpowered to detect any plausible true level of risk reduction”.
(p5)
We agree and the small sample sizes and frequent lack of sample size calculations were discussed in the review.
“There is uncertainty as to how valid either estimate is, given the heterogeneity. The dubious nature of the random effects esti-
mate…together with its wide CI, provides little evidence against chlorhexidine actually reducing risk of SSI” (p6)
We agree, there is a great deal of uncertainty around the individual study estimates and hence the pooled estimates however we are not
claiming that chlorhexidine increases the risk of SSI. We believe that amending the review conclusions to “no clear evidence of benefit”
from “evidence of no benefit” will deal with this issue.
“For the two studies where the comparison is with no wash both (pooled) estimates… show a non significant reduction in risk of SSI…
the data are difficult to interpret, because there are two widely differing estimates…both with very wide CIs”. (p7)
We agree that there is great heterogeneity here and it is probably not sensible to pool these studies; we have amended the review and
removed the pooling. This does not, however, materially affect the overall conclusions.
“It would seem not unreasonable to carry out an additional analysis using data for each study comparing the chlorhexidine whole body
group with the combined results for each study with no chlorhexidine…” (p7)
We don’t see the rationale for this additional analysis; it was not pre-planned in the protocol (unlike all the analyses presented) and it
would not alter the conclusions.
“I find the conclusions of the authors of the Cochrane review … to be surprising and misleading… even if they did mean ”evidence of
no benefit“ it does not seem justified bearing in mind that
i) two of the six studies showed a statistically significant advantage to chlorhexidine
ii) all the meta analyses (with the minor exception of the dubious random effects analysis for soap) provided estimates less than 1.00
i.e., an advantage to chlorhexidine, and
iii) the meta analyses based on the largest numbers of SSIs showed a near significant advantage to chlorhexidine.. My own conclusion
is that the data suggest a possible advantage to chlorhexidine but that more studies are needed.” (p8)
We agree that the conclusions are erroneously worded and have been amended to “no clear evidence of benefit for preoperative showering
or bathing with chlorhexidine…” We note that:
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i) the two studies that showed a statistically significant advantage associated with chlorhexidine were not of high quality (by pre-specified
quality criteria).
ii) none of the meta analyses showed a statistically significant advantage in favour of chlorhexidine.
iii) Mr Lee’s own analysis (which is post hoc unlike the pre-planned analyses presented in the Cochrane review) is the most favourable
to chlorhexidine but still not significant.
Other issues:
“It is stated on page 5 that for four of the included trials (Byrne 1992, Earnshaw 1989, Randall 1983, Wihlborg 1987) the authors
’responded to queries about study methods and/or requests for additional unpublished information.’ It is interesting to note that in
various places in the review there is reference to information from some of these studies as unknown or unclear. Were the original
authors not asked about this, or did they no longer remember or have records of the relevant details?”
The authors were unable to recall or obtain these details.
“The assessment of quality is in fact inconsistently described. In the section ’Methodological quality assessment’ on p4 it is stated that
trials were coded on six criteria…it is then stated that trials were defined as ”high quality“ based only on receiving an A rating for
criteria 2 and 3, making one wonder why criteria 1, 4, 5 and 6 were coded at all… However, in the ’Data synthesis’ section on p5 it
was stated that the effect of trial quality was carried out based on excluding those trials most susceptible to bias based on three criteria;
two (2 and 4) essentially as defined above and another not mentioned before… the fact that the authors have been inconsistent in their
definitions is not crucial to the selection of which studies are considered to be of high quality.”
The other criteria were coded to facilitate full discussion of all aspects of quality. We have amended the inconsistency in the explanation
of how trial quality was used in sensitivity analysis and agree that this does not affect the results or conclusions.
“On page 15, comparison 05 ’More than one wash versus one wash’ is stated to have an effect size of 0.92 (95% CI 0.80-1.04). This
is totally misleading and the relative risk has nothing whatsoever to do with how risk of SSI depends on the number of washes! Similar
problems relate to the comparison of individual versus cluster randomisation.”
We agree and have removed these subgroup analyses, however, this does not materially affect the overall results or conclusions.
Contributors
Joan Webster and Sonja Osborne, authors of the review.
Gill Worthy, Statistical Editor Cochrane Wounds Group.
Nicky Cullum, Coordinating Editor Cochrane Wounds Group.
PN Lee, Statistics and Computing Ltd (Independent Statistical Consultant to Mölynlycke Health Care).
Milt Hinsch, Technical Services Director, Mölynlycke Health Care.
Full text of the letter from Mölynlycke Health Care and the report of Mr Lee are available from the Editorial base, please contact Sally
Bell-Syer (email: sembs1@york.ac.uk).
WH A T ’ S N E W
Last assessed as up-to-date: 12 November 2010.
Date Event Description
30 August 2011 Amended republish, update affiliations, risk of bias terminology
46Preoperative bathing or showering with skin antiseptics to prevent surgical site infection (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
H I S T O R Y
Protocol first published: Issue 4, 2004
Review first published: Issue 2, 2006
Date Event Description
13 November 2010 New search has been performed Third update. New search, no new studies added.
Three new excluded studies (Edminson 2010; Eiselt
2009; Jakobsson 2010. No change to conclusions.
16 March 2009 New search has been performed Second update. One new study added (Veiga 2009).
Three new excluded studies (Veiga 2008; Kaiser 1988;
Enjabert 1984).
’Risk of Bias’ and ’Summary of Findings’ tables added.
23 July 2008 Amended Converted to new review format.
6 February 2007 New citation required and conclusions have changed Substantive amendment. Feedback added and authors’
response added
C O N T R I B U T I O N S O F A U T H O R S
JW conceived, designed, coordinated the review and conducted the initial literature search. The protocol was jointly written by JW
and SO. JW and SO separately reviewed the abstracts and selected papers for review. JW and SO separately reviewed and scored the
trials. Both authors contributed to the final version of the review. JW lead the update of the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• School of Nursing and Midwifery, Griffith University, Brisbane, Australia.
• School of Nursing and Midwifery, Queensland University of Technology, Queensland, Australia.
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External sources
• NIHR/Department of Health (England), (Cochrane Wounds Group), UK.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Anti-Infective Agents, Local [∗administration & dosage]; Baths [∗methods]; Chlorhexidine [administration & dosage; ∗analogs &
derivatives]; Disinfection [methods]; Preoperative Care [∗methods]; Randomized Controlled Trials as Topic; Soaps [administration &
dosage]; Surgical Wound Infection [∗prevention & control]
MeSH check words
Female; Humans; Male
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